Illumina

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Illumina 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ILMN

Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through the Core Illumina segment, which serves customers in the research, clinical and applied markets fields, and enables the adoption of a variety of genomic solutions. 

CEO
Jacob Thaysen
CEOJacob Thaysen
Employees
10,370
Employees10,370
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
1998
Founded1998
Employees
10,370
Employees10,370

ILMN Key Statistics

Market cap
19.67B
Market cap19.67B
Price-Earnings ratio
28.84
Price-Earnings ratio28.84
Dividend yield
Dividend yield
Average volume
1.87M
Average volume1.87M
High today
$132.15
High today$132.15
Low today
$128.27
Low today$128.27
Open price
$129.88
Open price$129.88
Volume
1.90M
Volume1.90M
52 Week high
$153.06
52 Week high$153.06
52 Week low
$68.70
52 Week low$68.70

Stock Snapshot

With a market cap of 19.67B, Illumina(ILMN) trades at $128.72. The stock has a price-to-earnings ratio of 28.84.

On 2025-12-02, Illumina(ILMN) stock traded between a low of $128.27 and a high of $132.15. Shares are currently priced at $128.72, which is +0.4% above the low and -2.6% below the high.

The Illumina(ILMN)'s current trading volume is 1.9M, compared to an average daily volume of 1.87M.

During the past year, Illumina(ILMN) stock moved between $68.70 at its lowest and $153.06 at its peak.

During the past year, Illumina(ILMN) stock moved between $68.70 at its lowest and $153.06 at its peak.

ILMN News

Simply Wall St 7d
How Will Analyst Reactions to ILMN’s Wolfe Conference Pitch Shape Confidence in Its Turnaround Plan?

Illumina, Inc. recently presented at the 7th Annual Wolfe Research Healthcare Conference in New York, where company leaders highlighted strategies to address ch...

How Will Analyst Reactions to ILMN’s Wolfe Conference Pitch Shape Confidence in Its Turnaround Plan?

Analyst ratings

46%

of 24 ratings
Buy
37.5%
Hold
45.8%
Sell
16.7%

People also own

Based on the portfolios of people who own ILMN. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.